Related Experiment Video
Updated: Jun 19, 2026

08:23
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
11.0K
Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke
Philipp J Koch1,2,3, Benedikt M Frey4, Winifried Backhaus4
1Department of Neurology, Neurovascular Center, University of Lübeck, Lübeck 23562, Germany.
Brain : a Journal of Neurology
|May 20, 2025
Summary
Neurotransmitter system damage after stroke impacts recovery more than structural damage alone. Specifically, disruptions in dopamine transporter networks correlate with poorer functional outcomes in stroke patients.
Area of Science:
- Neuroscience
- Neurology
- Systems Neuroscience
Background:
- Neuropsychiatric disorders are increasingly viewed as network diseases.
- Neurotransmitter (NT) system alterations are key to disease development.
- Limited research connects whole-brain NT fingerprints to stroke outcomes.
Purpose of the Study:
- Integrate NT data with structural connectivity for stroke analysis.
- Understand NT system's contribution to stroke outcome variability.
Main Methods:
- Combined normative NT receptor/transporter data with structural connectomes.
- Generated NT-specific connectivity maps (serotonin, dopamine, GABA, glutamate, acetylcholine).
- Analyzed lesion data from 126 stroke patients using logistic regression, adjusting for covariates.
Main Results:
- Developed a novel method integrating PET tracer NT data with connectomes.
- NT-informed maps showed distinct spatial distributions.
- Damage to dopamine transporter (DAT) networks significantly predicted poorer stroke recovery.
Conclusions:
- Lesion-induced NT system disruptions offer greater insight into stroke outcome variability than structural damage alone.
- Disruptions in dopaminergic networks play a crucial role in stroke recovery.
- Findings support personalized medicine approaches in stroke care, including targeted pharmacologic interventions.

